Dynavax and Sinovac Announce Collaboration to Develop a Coronavirus (COVID-19) Vaccine

EMERYVILLE, Calif., April 16 (Korea Bizwire) – Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, and Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that they have entered into a collaboration to develop a vaccine to prevent COVID-19. The collaboration will evaluate the combination of [...]